XCO receives $800,000 WINN funding
XCO Tech Inc., Penticton BC, has received the financial backing of the Federal Government for its development of breakthrough products for sport performance training and concussion assessment. The firm uses its proprietary technology that provides insightful digital biomarkers to better guide training, rehabilitation and treatment.
The commercial promise of XCO Tech Inc.’s innovative technology that precisely analyzes human motion, biometrics and cognition will receive $800,000 in funding via the Western Innovation (WINN) initiative, a program of Western Economic Diversification Canada (WD). The funding will help XCO commercialize its proprietary wearable XPS and BioAnalytics technologies, aimed at delivering an innovative sport performance training and rehabilitation product together with a comprehensive concussion assessment system.
XCO’s products are enabled by the firm’s technology platform, which fuses motion tracking outcome measures with biometrics and cognitive digital biomarkers to provide objective insight into human performance and health. XCO’s biomed solutions will enhance the performance of athletes in professional and amateur sports, as well as, aid in the treatment and rehabilitation of concussed and injured individuals. Scott McMillan, CEO of XCO, said the WINN funding complements the financial support from other government programs and from the company’s private investors.
“The funding will accelerate our testing and manufacturing of the sport performance and concussion products and as a result, XCO is on track to achieve its goals of commercial market introduction in 2019,” says McMillan. “The WINN funding by the federal government is a vote of confidence in our vision to help every athlete achieve breakthrough performance, improve safety in sports and have a real impact on patients’ health by using objective data to accurately assess those individuals,” he adds.